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Abstract
Introduction
Previous studies have shown racial and ethnic differ-
ences in diabetes complication rates and diabetes con-
trol. The objective of this study was to examine racial
and ethnic differences in diabetes care and health care
use and costs for adults with diabetes using a nationally
representative sample of the U.S. noninstitutionalized
civilian population.
Methods
We performed a cross-sectional analysis of the 2000
Medical Expenditure Panel Survey (MEPS) and its related
Diabetes Care Survey. The respondents were adults (aged
18 years and older) with diabetes, including non-Hispanic
whites, non-Hispanic African Americans, and Hispanics.
Racial and ethnic differences were examined in diabetes
process of care and health care use and costs using logistic
regression, negative binomial regression, and ordinary
least squares regression with log cost.
Results
Most of the outcomes in diabetes care management,
treatment, and complications were not significantly differ-
ent among race groups. After adjusting for socioeconomic
and demographic characteristics, Hispanics were more
likely to have eye problems than whites (odds ratio, 1.56;
95% confidence interval, 1.03–2.56). African Americans
and Hispanics had lower total health care costs, lower
ambulatory care costs, and lower prescription drug costs
than whites (P < .01 for all).
Conclusions
We found differences in ambulatory care and prescrip-
tion drug fills among white, African American, and
Hispanic adults with diabetes. However, most of the dia-
betes care measures were not significantly different among
the three racial and ethnic groups. Understanding the rea-
son outcomes do not differ when health care use and costs
differ significantly should be a focus of future studies.
Introduction
Diabetes is one of the most prevalent diseases in the
United States (1), resulting in considerable morbidity and
mortality and causing an enormous economic burden (2-4).
Reducing the incidence of diabetes and its economic bur-
den is one of the goals of the U.S. federal government in
Healthy People 2010 (5). In 2005, approximately 7% of indi-
viduals (20.8 million people) in the United States had dia-
betes; 14.6 million people were diagnosed and 6.2 million
people were undiagnosed (1). The prevalence of diabetes
varies greatly by race and ethnicity (1,4,6-8).
Approximately 13.3% of non-Hispanic African Americans,
9.5% of Hispanics and Latinos, and 8.7% of non-Hispanic
whites (all aged 20 years or older) have diabetes (1).
Previous studies have shown that African Americans and
Hispanics have higher rates of diabetes complications than
whites, including end-stage renal disease, retinopathy,
blindness, neuropathy, and lower extremity amputation
(9-13). Inadequate access to medical care and disparate
quality of diabetes care may contribute to racial or ethnic
differences in diabetes-related complications (5,14).
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.
www.cdc.gov/pcd/issues/2006/jul/05_0196.htm • Centers for Disease Control and Prevention 1
Jung-Ah Lee, MN, RN, Chuan-Fen Liu, PhD, MPH, Anne E. Sales, PhD, RNVOLUME 3: NO. 3
JULY 2006
Racial and ethnic differences in health insurance cover-
age for adults with diabetes have been reported (15). In
addition, there is evidence of racial and ethnic differences
in diabetes care. Non-Hispanic African American women
and Hispanic men treated with insulin and oral agents
were disproportionately represented among those with
poor glycemic control reported in a study using national
survey data (9), possibly resulting in increased medical
care costs for individuals with diabetes.
Examining racial and ethnic differences in health care
use and costs by using a nationally representative sam-
ple provides important information for addressing racial
and ethnic disparities in health care and may help
improve health care delivery. Racial variation in health
care services for diabetes care has been examined among
elderly Medicare beneficiaries (16). However, few studies
compared racial and ethnic differences in health care
costs as well as health care use for adults with diabetes
in general populations.
Our study had two aims: 1) to examine racial and ethnic
differences in diabetes care including diabetes manage-
ment, treatment, and complications and 2) to examine
racial and ethnic differences in health care use and costs
among adults with diabetes. We used the 2000 Medical
Expenditure Panel Survey (MEPS), a nationally represen-
tative sample of the civilian, noninstitutionalized U.S. pop-
ulation, which provides a unique opportunity for studying
racial and ethnic differences in diabetes care and health
care use and costs.
Methods
Data source
The study used data from the household component (HC)
of the 2000 MEPS, a survey sponsored by the Agency for
Healthcare Research and Quality (AHRQ) and the
National Center for Health Statistics (NCHS). We used the
2000 full-year consolidated data files (HC-050) from the
MEPS HC survey, which contained questions on demo-
graphic characteristics, health conditions, health status,
and use and expenditure of medical services. The overall
response to the 2000 MEPS was 65.8% (17).
In addition, the 2000 MEPS consolidation file included
disease-specific information from a series of surveys that
included diabetes. In the beginning of calendar year 2000,
MEPS conducted a new series of interviews as part of
AHRQ’s focus on quality of health care, asking questions
about several specific medical conditions such as diabetes,
asthma, high blood pressure, heart disease (including coro-
nary heart disease, angina, and myocardial infarction),
stroke, emphysema, and joint pain  (17). HC respondents
received A Survey About Your Diabetes Care — The
Diabetes Care Survey, a self-administered paper-and-pen-
cil questionnaire, if they responded yes to a question about
whether their diabetes had been diagnosed by a health
care professional.
The Diabetes Care Survey is a series of questions (18)
about diabetes management and includes the number of
times respondents reported having a glycated hemoglo-
bin A1c (HbA1c) test, the number of times they reported
having their feet checked for sores or irritation in 2000,
and the last time they reported having an eye examina-
tion. Respondents were also asked to report on diabetes
treatment (diet, oral medications, and insulin) and com-
plications (eye problems and kidney problems caused by
diabetes). Lower extremity amputation, a serious compli-
cation of diabetes, and type and duration of diabetes were
not included in the Diabetes Care Survey. The response
rate for the Diabetes Care Survey was 91.4% (17).
Study subjects
Out of 24,791 respondents to the 2000 MEPS, 1021
adults (18 years and older) with diabetes responded to
the Diabetes Care Survey. Race in this study was defined
using two variables in MEPS indicating race (categorized
as American Indian, Aleut Eskimo, Asian and Pacific
Islander, black, and white) and ethnicity (categorized as
Hispanic, non-Hispanic African American, and other).
The race variable in this study was categorized into three
groups including non-Hispanic white, non-Hispanic
African American, and Hispanic. We excluded American
Indians, Aleut Eskimos, and Asian Americans and Pacific
Islanders because the number of respondents (37 out of
1021 total adult Diabetes Care Survey respondents, or
3.6%) was too small to analyze. Thus, the final sample
size was 984 adults (18 years and older) with diabetes, of
whom 540 (54.9%) were white, 210 (21.3%) African
American, and 234 (23.8%) Hispanic. Population weights
from the full-year sample were used to generate esti-
mates for the national population of adults with diabetes
as of the index date December 31, 2000. The population
2 Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2006/jul/05_0196.htm
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.weighted study sample represents 16,808 adults with dia-
betes in 2000.
Health care use and costs
Health care use included ambulatory care visits and pre-
scription drug fills. Ambulatory care visits in both office-
based settings and hospital outpatient settings were
included. Physician and nonphysician visits were included
in ambulatory care visits. Nonphysicians included nurse
practitioners, physician assistants, chiropractors, podia-
trists, physical and occupational therapists, and social
workers. Prescription fills were defined as all prescribed
medications purchased in 2000.
Health care costs in MEPS were defined as direct
payments rather than charges by providers, including
out-of-pocket costs and third-party payments (17).
Administrative costs (i.e., costs not directly related to
patient care), over-the-counter drugs, and payments for
alternative care services were not included in MEPS. The
three components of health care costs in this study includ-
ed ambulatory care costs, prescription drug costs, and total
health care costs.
Ambulatory care costs included payment for providers in
office-based settings and hospital-based settings. The cost
of prescription fills includes all amounts paid out-of-pocket
and by third-party payers for prescribed medications pur-
chased in 2000. Total health care costs were defined as the
sum of payments for care for ambulatory care visits, hos-
pital inpatient stays with zero-night admission, emergency
department visits, dental care, home health care, and
other care including vision aids, medical supplies and
equipment, and prescription medications.
Diabetes care
Process and outcome measures specific to diabetes care
included management, treatment, and diabetes-related
complications. Diabetes care management included
whether the respondents had received an HbA1c test, had
had their feet checked for sores or irritation, and had
received an eye examination. Diabetes treatment included
diet modification, oral medications, and insulin therapy
reported by Diabetes Care Survey respondents. The vari-
ables for diabetes complications included eye and kidney
problems caused by diabetes. In this study, all measures
were binary (yes or no) variables using the original MEPS
variables in the Diabetes Care Survey for statistical analy-
sis. Positive answers were coded 1; for example, having
received any HbA1c test was coded as 1 if a Diabetes Care
Survey respondent reported having received one or more
than one HbA1c test; we recorded 0 otherwise.
Statistical analysis
Table 1 shows the definitions of dependent and independ-
ent variables. The primary independent variable of interest
is race. Covariates included age, sex, education, marital sta-
tus, living in a standard metropolitan statistical area (MSA),
income, health insurance, having a usual source of care
(USC) provider, self-rated health status, employment, and
comorbidity in multivariate analyses. Having a USC is a
commonly used measure of access to care.
The data were analyzed using bivariate and multivari-
ate methods with Stata 7 (Stata Corp, College Station,
Tex). Chi-square (χ2) tests were used to compare racial and
ethnic differences in individual characteristics. Logistic
regression was used to examine differences in diabetes
care among the three racial and ethnic groups (white,
African American, and Hispanic). For multivariate analy-
ses of utilization measures, which are count variables, we
used count data methods (19). Because utilization data are
usually not normally distributed and tend to have a long
heavy right tail, distributions do not satisfy the assump-
tions for ordinary least squares regression, which include
normality, homoscedasticity, and independence of error
terms. We used negative binomial regression models to
analyze health care use outcomes (20-23). Incidence rate
ratios (IRRs) from negative binomial regression models
were used to compare incidence rates of ambulatory care
use and prescription fills among three racial and ethnic
groups. For example, if the IRR for ambulatory care visits
among African Americans is 0.8, the interpretation is that
being African American decreases the expected number of
visits compared with whites by a factor of 0.8, holding
other variables constant. In other words, being African
American decreases the expected number of ambulatory
care visits by 20% (20).
We performed a natural logarithmic transformation
of the cost variables to compensate for the nonnormal
distribution and high degree of right skewing. In the
regression model using the log transformation for
costs, we can interpret the coefficients (β) as percent
changes for a change in a dummy variable from zero to
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one by calculating exponentiation of the β coefficient – 1
(exp [β] – 1) (24,25).
All analyses were adjusted for the complex survey design
used in MEPS (17). The 2000 MEPS diabetes weights from
the Diabetes Care Survey were used for the diabetes care
analyses to yield valid estimates. The MEPS person-level
weights were used for health care use and cost analyses to
yield valid national estimates for individuals with diabetes
(17). The University of Washington Human Subjects
Committee determined this study to be exempt from
human subjects review.
Results
Baseline demographic characteristics
Table 2 presents demographic characteristics for adults
with diabetes by racial and ethnic group. Among adults
with diabetes, we found statistically significant differences
across racial and ethnic groups in age, sex, education, mar-
ital status, income, insurance, and comorbidity. The mean
age of adults with diabetes was 60 (61 among whites, 59
among African Americans, and 57 among Hispanics, P =
.006). The proportion of women was highest among African
Americans (66%), followed by whites (53%) and Hispanics
(51%) (P = .04). African Americans had the lowest propor-
tion of married individuals (36%), followed by Hispanics
(53%) and whites (62%) (P < .001). Whites had the highest
proportion of individuals with a high school education or
more (77%), followed by African Americans (68%) and
Hispanics (51%) (P < .001). More than half of African
Americans (55%) were low income, compared with 45% of
Hispanics and 32% of whites (P < .001). Most whites (97%)
and African Americans (93%) had health insurance at
least some of the time in 2000, but only 80% of Hispanics
did (P < .001). Whites (72%) were significantly more likely
to have private insurance than African Americans (50%) or
Hispanics (40%) (P < .001), whereas African Americans
(24%) and Hispanics (28%) were significantly more likely
to be enrolled in Medicaid than whites (8%) (P < .001). The
proportion of individuals having a USC was similar among
the racial and ethnic groups (96% for whites, 94% for
African Americans, and 90% for Hispanics, P = .12).
Seventy-one percent of African Americans were concomi-
tantly diagnosed with high blood pressure, compared with
64% of whites and 49% of Hispanics (P = .01). Whites had
the highest proportion of concurrent heart disease with
diabetes (35%), compared with 23% among African
Americans and 14% among Hispanics (P < .001).
Diabetes care
Table 3 presents unadjusted diabetes process-of-care
measures by racial and ethnic group. Most of the diabetes
care measures, including management, complications, and
treatment, were not significantly different among racial
and ethnic groups. However, dilated-eye examination rates
were significantly different among the groups (95% among
whites, 90% among African Americans, and 86% among
Hispanics, P = .02). The probability of having eye problems
caused by diabetes also differed significantly across the
three groups (23% among whites, 33% among African
Americans, and 33% among Hispanics, P = .03).
Table 4 presents adjusted odds ratios (ORs) for diabetes
care by racial and ethnic group. After adjusting for covari-
ates, Hispanics were more likely than whites to have eye
problems from diabetes complications (OR, 1.56; 95% CI,
1.03–2.56). We found no significant differences in other
measures of diabetes management, complications, and
treatment and among racial and ethnic groups after
adjustment.
Health care use and costs
Table 5 summarizes unadjusted health care use and
costs. The probability of using ambulatory care was signif-
icantly different among groups (P = .04), but we found no
significant difference in the mean number of ambulatory
care visits. Whites were more likely to use ambulatory care
(96%), followed by African Americans (92%) and Hispanics
(89%). We found no significant difference in the probabili-
ty of having a prescription fill among the groups. However,
whites filled more prescriptions (38.3 fills), followed by
African Americans (29.8 fills) and Hispanics (29.8 fills) (P
= .002).
We found significant differences in ambulatory care
costs and prescription drug costs among the three groups.
Whites had the highest ambulatory care costs ($1783), fol-
lowed by African Americans ($1654) and Hispanics ($1028)
(P = .03). The prescription drug costs among the three
groups were $1886 for whites, $1419 for Hispanics, and
$1392 for African Americans (P < .001). Although we found
no significant difference in total health care costs among
the racial and ethnic groups, the proportion by level of pay-
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Approximately one third of total health care costs was paid
by private insurance among whites. Medicaid paid more
health care costs for African Americans ($985) and
Hispanics ($803) than whites ($374) (P = .01).
Table 6 presents adjusted health care use and costs.
Compared with whites, African Americans were less likely
to have ambulatory care use (IRR, 0.71; 95% CI,
0.58–0.87) and prescription fills (IRR, 0.73; 95% CI,
0.63–0.83). After adjustment, we found no significant dif-
ferences between whites and Hispanics in the probability
of having ambulatory care use and prescription fills.
Compared with whites, African Americans had 25%
lower total health care costs (P = .008), 51% lower ambu-
latory care costs (P < .001), and 36% lower prescription
drug costs (P < .001). Hispanics also had 31% lower total
health care costs (P = .006) and 58% lower ambulatory care
costs (P = .003) than whites.
Discussion
Using a nationally representative sample to examine
variation across racial and ethnic groups in diabetes
process of care, as well as health care use and costs for
adults with diabetes, we found that self-reported processes
of care for diabetes, including management, complications,
and treatment, were not significantly different among
whites, African Americans, and Hispanics, except in the
rate of dilated-eye examination, which was lower among
Hispanics. In addition, African Americans and Hispanics
incurred lower health care costs than whites.
Consistent with previous studies (26,27), we did not find
significant differences among the three groups in HbA1c
testing or examining feet for sores. These results may be
related to the characteristics of the study sample partici-
pants, most of whom had insurance (94%). Most also had a
USC provider (95%). However, this study found a higher
proportion of adults (more than 90%) with diabetes report-
ing having had a dilated-eye examination in 1 year than a
study using data from the Third National Health and
Nutrition Examination Survey (NHANES III), which
found a rate of 60% to 70% (26). Some published studies
have found that Hispanics have a higher prevalence of dia-
betic retinopathy than non-Hispanic whites (28,29), and
this study also found that Hispanics were more likely to
have self-reported eye problems than whites. However, no
significant difference was found in self-reported eye prob-
lems between African Americans and whites in this study.
This finding is similar to the findings in the Harris et al
study, which also used NHANES III data (13).
A study by Karter et al (10), which was based on patients
from Kaiser Permanente Medical Care Program in north-
ern California, found that African Americans and
Hispanics had higher rates than whites of microvascular
complications, in particular end-stage renal disease, but
our study did not find a racial and ethnic difference in self-
reported kidney problems. The differences in results
regarding kidney problems may be a result of differences
in the study samples.
We also found no racial and ethnic difference in diabetes
treatment with oral agents, insulin, or both. The percent-
age of those treated with insulin among the groups (white,
28%; African American, 38%; Hispanic, 24%) was similar
to the percentage identified in a previous study (26).
However, our study found a high proportion (57%) of
adults with diabetes taking oral agents alone for glucose
control than the study using NHANES III data (26) (which
found less than 50% across racial and ethnic groups).
We found that African Americans were less likely to
have ambulatory care and prescription fills than whites.
Results show significant differences among groups in the
proportion of individuals with a high school education or
more. These differences in education may affect aware-
ness of health-care seeking behaviors for preventive
care, which may result in differences in use among dif-
ferent races and ethnicities.
After controlling for all other factors, African Americans
and Hispanics had significantly lower total health care
costs, ambulatory care costs, and prescription costs than
whites. Several reasons may explain the cost differences
among groups. First, the differences may stem from differ-
ences in health care use. Despite similar access to care, we
found that African Americans were less likely to have
ambulatory care visits and prescription fills than whites
(measured by insurance coverage and having a USC).
Second, the cost differences may reflect payment differ-
ences among types of health insurance coverage. Although
the majority of adults with diabetes were insured at some
point in 2000 (94%), we found remarkable differences in
having private insurance or being on Medicaid among the
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groups. Medicaid payments are commonly lower than pay-
ments from private insurance. Because health care costs in
MEPS were defined as direct payments to providers rather
than charges, the lower health care costs among African
Americans and Hispanics may partially reflect lower pay-
ments from Medicaid. Finally, the cost difference may also
reflect access to different types of services caused by dif-
ferences in insurance coverage among the racial and eth-
nic groups. Individuals with private insurance may have
greater access to higher-cost procedures than those on
Medicaid (30). It is also possible that rates of service use
accompanying higher costs among white individuals with
diabetes may reflect inefficient practice and possibly
effects of supplier-induced demand (31).
This study has several limitations. First, diabetes
process-of-care measures were self-reported and may be
subject to recall bias. However, health care use and costs
were validated by direct contact with medical providers,
pharmacies, and health insurance companies identified by
household respondents in MEPS (17).
Second, some important factors such as the duration,
type, and severity of diabetes, which are critical factors for
disease-severity adjustment in comparing differences in
diabetes care and health care use and costs, were not
included in the survey. However, we used self-rated
health status and comorbidity to control for case mix.
Finally, individuals with undiagnosed diabetes were not
included in MEPS. Therefore, racial and ethnic disparities
for individuals with undiagnosed diabetes, which might be
more substantial than for those with diagnosed diabetes,
are still unknown. Harris et al (26) reported in 1998 that
6% of the U.S. population 40 to 74 years of age had undi-
agnosed diabetes and 11% of the U.S. population aged 60
to 74 years had undiagnosed diabetes.
Our study provides insight into racial and ethnic differ-
ences in diabetes process of care and health care use and
costs. African American and Hispanic adults with diabetes
had lower health care use and incurred lower costs than
whites, particularly in ambulatory care visits and prescrip-
tion fills. Future studies should focus on the underlying
causes of these racial and ethnic differences in health care
use among diabetes to reduce racial and ethnic disparities
in diabetes care and should include longitudinal, prospec-
tive studies to explore the dynamic effects of changes in
health insurance and other socioeconomic factors over time.
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Tables
Table 1. Dependent and Independent Variables for Racial and Ethnic Differences in Diabetes Care and Health Care Use and
Costs
Dependent variables
Diabetes care Binary variable (yes = 1, no = 0)
Management
Hemoglobin A1c Hemoglobin A1c test
Feet check Feet checked for sores
Eye examination Eye examination with pupils dilated
Complication
Kidney problems Kidney problems caused by diabetes
Eye problems Eye problems caused by diabetes
Treatment
Diet modification Diet modification
Oral medication Oral medication
Insulin Insulin injection
Health care use
Ambulatory care visits Number of visits (physician and nonphysician) to office-based and hospital outpatient settings
Prescription fills Number of all prescribed medications purchased in 2000
Health care costs
Total health care costs Sum of all costs for ambulatory care visits, prescription fills, inpatient care, emergency department visits, dental care, 
and home health care
Ambulatory care costs Costs of ambulatory care visits (physician and nonphysician) in office-based and hospital outpatient settings
Prescription drug costs Costs paid out-of-pocket and by third-party payers for all prescribed medications purchased in 2000
Independent variables
Race
White 1 = non-Hispanic white; 0 = otherwise
Black 1 = non-Hispanic African American; 0 = otherwise
Hispanic 1 = Hispanic; 0 = otherwise
Age 18 years or older
Elderly 1 = 65 years or older; 0 = otherwise
Sex 1 = female; 0 = male
Education 1 = high school or more; 0 = less than high school
Marital status 1 = married; 0 = widowed, divorced, separated, or never married
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Variablesa Definition
aCovariates in multivariate regression analyses. (Continued on next page)Independent variables (Continued)
Metropolitan statistical area (MSA) 1 = living in MSA; 0 = otherwise
Income 1 = >200% of poverty line; 0 = <200% of poverty line
Employment 0 = unemployed during all of 2000; 1 = otherwise
Health insurance status 1 = having health insurance any time in 2000; 0 = otherwise
Usual source of care (USC) 1 = having a USC provider; 0 = no
Perceived health status (physical  1 = self-ranked excellent, very good, or good; 0 = fair or poor
and mental health status)
Comorbidity 1 = having any chronic conditions including high blood pressure, heart diseases (e.g., angina, myocardial infarction, 
coronary, other), or stroke; 0 = none of above
aCovariates in multivariate regression analyses.
Table 2. Baseline Demographic Characteristics of Adults With Diabetes, Based on Data From Household Component of 2000
Medical Expenditure Panel Surveya
Age, y, mean (SE) 60.7 (0.81) 58.7 (0.94) 56.8 (1.17) 59.9 (0.65) .006
Elderly (65 y or older), % 45 37 37 43 .22
Female, % 53 66 51 55 .04
High school education or above, % 77 68 51 72 <.001
Married, % 62 36 53 57 <.001
Living in metropolitan statistical area, % 72 80 90 75 .08
Income
Middle/high, % 68 45 55 62 <.001
Low/poor, % 32 55 45 38
Unemployed in all of 2000, % 55 58 53 55 .84
Insured any time in 2000, % 97 93 80 94 <.001
Payment source
Medicare, % 52 46 42 50 .10
Medicaid, % 8 24 28 13 <.001
Private insurance, % 72 50 40 64 <.001
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Table 1. (continued) Dependent and Independent Variables for Racial and Ethnic Differences in Diabetes Care and Health
Care Use and Costs
Variablesa Definition
White African American Hispanic Total
Characteristic (n = 540) (n = 210) (n = 234) (N = 984) P Value
aThe results are adjusted by population weights. (Continued on next page)VOLUME 3: NO. 3
JULY 2006
With a usual source of care provider, % 96 94 90 95 .12
Good/excellent perceived physical health, % 62 58 55 61 .64
Good/excellent perceived mental health, % 87 78 84 85 .09
Comorbidity
High blood pressure, % 64 71 49 64 .01
Heart disease (angina, myocardial  35 23 14 31 <.001
infarction, coronary, other), %
Stroke, % 8.8 8.4 8.1 8.6 .99
Any comorbidity conditions above, % 75 74 53 72 <.001
aThe results are adjusted by population weights.
Table 3. Racial and Ethnic Differences in Diabetes Process of Care Among Adults With Diabetes, Based on Data From
Household Component of 2000 Medical Expenditure Panel Surveya (N = 984)
Management
Hemoglobin A1c 91 86 85 89 .26
Feet checked 68 60 66 66 .48
Dilated-eye examination 95 90 86 93 .02
Complications
Kidney problems 15 14 19 15 .81
Eye problems 23 33 33 26 .03
Treatment
Diet modification 83 82 83 83 .99
Oral medication 70 74 76 72 .65
Insulin 28 38 24 29 .09
aThe results are adjusted by population weights.
10 Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2006/jul/05_0196.htm
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.
Table 2. (continued) Baseline Demographic Characteristics of Adults With Diabetes, Based on Data From Household
Component of 2000 Medical Expenditure Panel Surveya
White African American Hispanic Total
Characteristic (n = 540) (n = 210) (n = 234) (N = 984) P Value
African 
Care Category White, % American, % Hispanic, % Total, % P ValueTable 4. Racial and Ethnic Differences in Diabetes Process of Care Among Adults With Diabetes, Adjusted,a Based on Data
From Household Component of 2000 Medical Expenditure Panel Survey
Management
Hemoglobin A1c Ref 0.62 (0.31-1.23) 0.98 (0.42-2.25)
Feet checked for sores Ref 0.70 (0.45-1.11) 1.04 (0.62-1.74)
Dilated eye examination Ref 0.54 (0.23-1.29) 0.54 (0.28-1.04)
Complication
Kidney problems Ref 0.62 (0.32-1.20) 1.04 (0.53-2.08)
Eye problems Ref 1.33 (0.86-2.03) 1.56 (1.03-2.56)
Treatment
Diet modification Ref 1.03 (0.67-1.58) 1.60 (0.89-2.88)
Oral medication Ref 1.27 (0.85-1.87) 1.48 (0.83-2.65)
Insulin Ref 1.38 (0.89-2.16) 0.69 (0.43-1.12)
OR indicates odds ratio; CI, confidence interval; Ref, reference group.
aAdjusted for age, sex, education, marital status, living in metropolitan statistical area, income status, insurance status, having a usual source of care
provider, self-rated health status, and comorbidity. All analyses were also adjusted for population weights.
Table 5. Racial and Ethnic Differences in Health Care Use and Costs Among Adults with Diabetes, Based on Data From
Household Component of 2000 Medical Expenditure Panel Surveya (N = 984)
Any ambulatory care use, % 96 92 89 95 .04
Mean no. of ambulatory care visits 13.6 10.6 10.4 12.6 .06
Any prescription drug use, % 98 98 93 97 .06
Mean no. of prescription fills 38.3 29.8 29.8 35.9 .002
Ambulatory care cost, $ (SE) 1783 (152) 1654 (298) 1028 (230) 1675 (125) .03
Prescription drug cost, $ (SE) 1886 (99) 1392 (100) 1419 (121) 1748 (74) <.001
Total cost, $ (SE) 6887 (465) 6162 (860) 5647 (725) 6616 (369) .35
Average payment by Medicare, $ (%)b 2674 (38.8) 1774 (28.8) 2311 (40.9) 2482 (37.5) .20
Average payment by Medicaid, $ (%) 374 (5.4) 985 (16.0) 803 (14.2) 527 (8.0) .01
Average payment by private insurance, $ (%) 1981 (28.8) 1184 (19.2) 967 (17.1) 1726 (26.1) .003
Average payment out of pocket, $ (%) 1371 (19.9) 880 (14.3) 1045 (18.5) 1251 (18.9) .004
aThe results are adjusted by population weights.
bProportion of total cost.
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Care Category White OR (95% CI) African American OR (95% CI) Hispanic OR (95% CI)
Categories White African American Hispanic Total P ValueVOLUME 3: NO. 3
JULY 2006
Table 6. Racial and Ethnic Differences in Health Care Use and Health Care Costs Among Adults With Diabetes, Adjusted,a
Based on Data From Household Component of 2000 Medical Expenditure Survey
Ambulatory care use, IRR (95% CI) Ref 0.71 (0.58-0.87) 0.82 (0.57-1.18)
Prescription fills, IRR (95% CI) Ref 0.73 (0.63-0.83) 0.88 (0.75-1.03)
Total health care costs, % changeb Ref –25 (P = .008) –31 (P = .006)
Ambulatory care costs, % changeb Ref –51 (P < .001) –58 (P = .003)
Prescription drug costs, % changec Ref –36 (P < .001) –20 (P = .24)
Ref indicates reference group; IRR, incidence rate ratio.
aAdjusted for age, sex, education, marital status, living in metropolitan statistical area, income status, insurance status, having a usual source of care
provider, self-rated health status, and comorbidity. All analyses were also adjusted for population weights.
b% change between African Americans and whites: exp (β coefficient) – 1.
c% change between Hispanics and whites: exp (β coefficient) – 1.
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Categories White African American Hispanic